Spreadsheet: f2518247-8e40-422a-9c7b-3028ff3e2e86
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
2C9S | Test | 2C9S | Cytochrome P450 2C9 Genotype by Sequence Analysis, Blood | CYP2C9 [NAME] | Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis |  |  |  | 3 | mL | This test is used for assessing CYP2C9 for polymorphisms affecting the metabolism of drugs other than warfarin/Coumadin. If requesting for the use of warfarin, order WARFP/60529 Warfarin Sensitivity Genotype which includes testing for the CYP2C9 gene and [NAME] gene promoter.  Multiple whole blood EDTA genotype tests can be performed on a single specimen after a single extraction. See Multiple Whole Blood EDTA Genotype Tests in Special Instructions for a list of tests that can be ordered together.  Container/Tube: Lavender top (EDTA) [NAME]: 3 mL Collection Instructions: Send specimen in original tube. Additional Information: 1. Bone marrow and liver transplants will interfere with testing. Call Mayo Medical Laboratories at [PHONE] or [PHONE] for instructions. 2. Transfusions will interfere with testing for up to 4 to 6 weeks. DNA obtained from white cells may not provide useful information for patients who received a recent transfusion of blood that was not leukocyte-reduced. Wait 4 to 6 weeks until transfused cells have left the patient's circulation before drawing the patient's blood specimen for genotype testing. 3. Cytochrome P450 Patient Education Brochure (Supply T526) is available upon request.  Forms: New York Clients-Informed consent is required. Please document on the request form or electronic order that a copy is on file. An Informed Consent for Genetic Testing (Supply T576) is available in Special Instructions. | 0.3 mL | Hemolysis	NA Thawing	NA Lipemia	NA Icterus	NA Other	NA | An interpretive report will be provided. | Varies | 5 days | 10 days | 1 | 81227 |  |  |  |  | Rochester
2C9S | [NAME] | WBEDTA | [NAME] EDTA |  |  |  | Ambient
2C9S | Component | 2C9 | Cytochrome P450 2C9 Genotype by Sequence Analysis | CYP2C9 Genotype | Only orderable as part of a profile. For further information see #60528 "CYP2C9 [NAME]." | EDTA (lavender-top) tube: EDTA |  |  | 3 | mL | Only orderable as part of a profile. For further information see #60528 "CYP2C9 [NAME]." | 0.3 mL |  | An interpretive report will be provided. |  |  |  | 1 | 81227 |  |  | Yes | No
2C9 | [NAME] | WBEDTA | [NAME] EDTA |  |  |  | Ambient
2C9 | Result | 32164 | CYP2C9 Phenotype Interpretation | CYP2C9 Phenotype Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
2C9 | Result | 32165 | CYP2C9 [NAME] | CYP2C9 [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 46724-1 | CYP2C9 gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
2C9 | Result | 24181 | CYP2C9 430C>T (*2) | CYP2C9 430C>T (*2) | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
2C9 | Result | 24182 | [NAME] (*6) | [NAME] (*6) | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
2C9 | Result | 24183 | CYP2C9 1075A>C (*3) | CYP2C9 1075A>C (*3) | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
2C9 | Result | 24184 | CYP2C9 1076T>C (*4) | CYP2C9 1076T>C (*4) | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
2C9 | Result | 24185 | CYP2C9 1080C>G (*5) | CYP2C9 1080C>G (*5) | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
2C9 | Result | 83652 | CYP2C9 Genotype Interpretation | CYP2C9 Genotype Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 46724-1 | CYP2C9 gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
2C9 | Result | 24186 | CYP2C9 Reviewed by | CYP2C9 Reviewed by | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
2C9S | Component | 2C9Q | CYP2C9 Sequencing | CYP2C9 Sequencing | Only orderable as part of a profile. For further information see #60528 "CYP2C9 [NAME]." |  |  |  |  |  |  |  |  |  |  |  |  | 6 |  |  |  | Yes | No
2C9Q | [NAME] | VARIES | Varies |  |  |  | Ambient
2C9Q | Result | 2C9Q | CYP2C9 Sequencing | CYP2C9 Sequencing | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process